Unusual occurrence of intestinal pseudo obstruction in a patient with maternally inherited diabetes and deafness (MIDD) and favorable outcome with Coenzyme Q10

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 8, 2008, Pages 1345-1349

  Bergamin, Carla S ^a   Rolim, Luiz Clemente ^a   Dm, Sergio A ^a   Moisés, Regina S ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Coenzyme Q10; MIDD; Pseudo intestinal obstruction

Indexed keywords

EID: 58849154522     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302008000800023     Document Type: Article

References (33)

1. Van den Ouweland JMH, Lemkes HHPJ, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA, et al. Mutation in the mitochondrial tRNALEU(UUR) gene in a large pedigree with maternally transmitted type II diabetes and deafness. Nat Genet. 1992;1(5):368-71.
2. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC. Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet. 1993;340(8832):1376-9.
3. Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R et al. A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med. 1994;330(14):962-8.
4. Di Mauro S, Schon, EA. Mechanisms of Disease: Mitochondrial Respiratory-Chain Diseases. N Engl J Med. 2003;348(26): 2656-68.
5. Maassen JA, 't Hart LM, van Essen E, Heine RJ, Nijpels G, Tafrechi RSJ, et al. Mitochondrial Diabetes. Molecular Mechanisms and Clinical Presentation. Diabetes, 2004;53 Suppl 1: S103-S109.
6. Oka Y, Katagiri H, Ishihara H, Asano T, Kobayashi T, Kikuchi M. Beta-cell loss and glucose induced signaling defects in diabetes mellitus caused by mitochondrial tRNALeu (UUR) gene mutation. Diabet Med. 1996;9 Suppl 6:S98-S102.
7. Velho G, Byrne MM, Clément C, Sturis J, Pueyo ME, Blanché H et al. Clinical phenotypes, insulin secretion, and insulin sensitivity in kindreds with maternally inherited diabetes and deafness due to mitochondrial tRNALeu (UUR) gene mutation. Diabetes. 1996;45(4):478-87.
8. Salles JE, Kasamatsu TS, Dib SA, Moisés RS. B-cell function in individuals carrying the mitochondrial tRNA Leu (UUR) mutation. Pancreas. 2007;34(1):133-7.
9. Saker PJ, Hattersley AT, Barrow B, Hammersley MS, Horton V, Gillmer MD, Turner RC. UKPDS 21: low prevalence of the mitochondrial transfer RNA gene (tRNA(Leu(UUR))) mutation at position 3243bp in UK Caucasian type 2 diabetic patients. Diabet Med. 1997;14(1):42-5.
10. Katagiri H, Asano T, Ishihara H, Inukai K, Anai M, Yamanouchi T, et al. Mitochondrial diabetes mellitus: prevalence and clinical characterization of diabetes due to mitochondrial tRNA (Leu(UUR)) gene mutation in Japanese patients. Diabetologia. 1994;37(5):504-10.
11. Ohkubo K, Yamano A, Nagashima M, Mori Y, Anzai K, Akehi Y, et al. Mitochondrial gene mutations in the tRNA(Leu(UUR)) region and diabetes: prevalence and clinical phenotypes in Japan. Clin Chem. 2001;47(9):1641-8.
12. Salles JE, Kalinin LB, Ferreira SRG, Kasamatsu T, Moisés RS. Diabetes mellitus associado à mutaģão mitocondrial A3243G: freqüência e caracterização clínica. Arq Bras Endocrinol Metab. 2007;51(4):559-65.
13. Crispim D, Tschiedel B, Souto KEP, Roisenberg I. Prevalence of three mitochondrial DNA mutations in type 2 diabetic patients from southern Brazil. Clin Endocrinol. 2002;57(1):141-2.
14. Hirano M, Silvestri G, Blake DM, Lombes A, Minetti C, Bonilla E, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive disorder. Neurology. 1994;44(4): 721-7.
15. Hess J, Burckhard P, Morris M, Laliot M, Myers P, Hadenque A. Ischaemic colitis due to mitochondrial cytopathy. Lancet. 1995;346(8968):189-90
16. Kishimoto M, Hashiramoto M, Kanda F, Tanaka M, Kasuga M. Mitochondrial mutation in diabetic patient with gastrointestinal symptoms. Lancet. 1995;345(8947):142.
17. Shimotake T, Furukawa T, Katsuhiro I, Iwai N, Takeuchi Y. Familial occurrence of intestinal obstruction in children with the syndrome of mitochondrial encephalomyopathy, lactic acidosis and stoke-like episodes (MELAS). J Pediatr Surg. 1998;33 (12):1837-9.
18. García-Velasco A, Gómez-Escalonilla C, Guerra-Vales JM, Cabello A, Campos Y, Arenas J. Intestinal pseudo-obstruction and urinary retention: cardinal features of a mitochondrial DNA-related disease. J Intern Med. 2003;253(3):381-5.
19. Narbonne H, Paquis-Fluckinger V, Valero R, Heyries L, Pellissier JF, Vialettes B. Gastrointestinal tract symptoms in Matternally Inherited Diabetes and Deafness (MIDD). Diabetes Metab. 2004;30(1):61-6.
20. Suzuki Y, Kadowaki H, Atsumi Y, Hosokawa K, Katagiri H, Kadowaki T, et al. A case of diabetic amyotrophy associated with 3243 mitochondrial tRNA(leu; UUR) mutation and successful therapy with Coenzyme Q10. Endocrine J. 1995;42(2):141-5.
21. Suzuki S, Hinokio Y, Ohtomo M, Hirai M, Hirai A, Chiba M, et al. The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia. 1998;41(5):584-8.
22. Suzuki Y, Taniyama M, Muramatsu T, Atsumi Y, Hosokawa K, Asahina T, et al. Diabetes mellitus associated with mitochondrial tRNA Leu (UUR) mutation: clinical features and Coenzyme Q10 treatment. Mol. Aspects Med. 1997;18 Suppl 1:S181-8.
23. Salles JE, Moisés VA, Almeida DR, Chacra AR, Moisés RS. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10. Diabetes Res Clin Pract. 2006;72(1):100-.
24. Guillausseau PJ, Massin P, Dubois-LaForgue D, Timsit J, Virally M, Gin H, et al. Maternally inherited diabetes and deafness: a multicenter study. Ann Intern Med. 2001;134(9):721-8.
25. Holmes-Walker DJ, Mitchell P, Boyages SC. Does mitochondrial genome mutation in subjects with maternally inherited diabetes and deafness decrease severity of diabetic retinopathy? Diabet Med. 1998;15(11):946-52.
26. Massin P, Dubois-Laforgue D, Meas T, Laloi-Michelin M, Gin H, Bauduceau B, et al. Retinal and renal complications in patients with a mutation of mitochondrial DNA at position 3,243 (maternally inherited diabetes and deafness). A case-control study. Diabetologia. 2008;51(9):1664-70.
27. Nakamura S, Yoshinari M, Doi Y, Yoshizumi H, Katafuchi R, Yokomizo Y, et al. Renal complications in patients with diabetes mellitus associated with an A to G mutation of mitochondrial DNA at the position 3243 of leucine tRNA. Diabetes Res Clin Pract. 1999;44(3): 183-9.
28. Aoki Y, Hosaka S, Kiyosawa K. Intestinal Pseudo-Obstruction in a Diabetic Man: Role of the Mitochondrial A3243G Mutation. Ann Intern Med. 2002;137(8):703-4.
29. Antonucci A, Fronzoni L, Cogliandro L, Cogliandro R, Stanghellini V, et al. Chronic intestinal pseudo-obstruction. World J Gastroenterol. 2008;14(19):2953-61.
30. Hiel JAP, Verrips A, Keyser A, Jansen TLTA, Wesseling P, Coo R, Gabreëls FJM. Ileus in mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes. Neth J Med. 1998;53 (1):27-31.
31. Campos Y, Martin MA, Caballero C, Rubio JC, de la Cruz F, Tu-ñón T, et al. Single large-scale mitochondrial DNA deletion in a patient with encephalopathy, cardiomyopathy, and prominent intestinal pseudoobstruction. Neuromuscul Disord. 2000;10(1):56-8.
32. Chimmery PF, Jones S, Sviland L, Andrews RM, Parsons TJ, Turnbull DM, et al. Mitochondrial enteropathy: the primary pathology may not be within the gastrointestinal tract. Gut. 2001;48(1):121-4.
33. Yamamoto M, Sato T, Anno M, Ujike H, Takemoto M. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with recurrent abdominal symptoms and coenzyme Q10 administration. J Neurol Neurosurg Psychiatry. 1987;50(11):1475-81.